{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:42:25Z","timestamp":1777081345223,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.clineuro.2003.09.005","type":"journal-article","created":{"date-parts":[[2003,12,9]],"date-time":"2003-12-09T11:54:27Z","timestamp":1070970867000},"page":"82-87","source":"Crossref","is-referenced-by-count":25,"title":["Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL)"],"prefix":"10.1016","volume":"106","author":[{"given":"Ralf","family":"Weigel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Senn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Weis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim K.","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2003.09.005_BIB1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00001622-199206000-00018","article-title":"Current concepts in leptomeningeal metastasis","volume":"4","author":"Chamberlain","year":"1992","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.1992.10.4.635","article-title":"Combined modality therapy for primary CNS lymphoma","volume":"10","author":"DeAngelis","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB3","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/1097-0142(19950615)75:12<2919::AID-CNCR2820751220>3.0.CO;2-9","article-title":"Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status","volume":"75","author":"Glantz","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1016077907952","article-title":"Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?","volume":"58","author":"Khan","year":"2002","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM197507242930402","article-title":"Methotrexate: distribution in cerebrospinal fluid after intravenous","volume":"293","author":"Shapiro","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/mpo.2950060304","article-title":"Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoir","volume":"6","author":"Bleyer","year":"1979","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V51.5.835.835","article-title":"\u201cConcentration \u00d7 time\u201d methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms","volume":"51","author":"Bleyer","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJM196212202672502","article-title":"Subarachnoid distribution of drugs after lumbar injection","volume":"267","author":"Rieselbach","year":"1962","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB9","first-page":"633","article-title":"Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration","volume":"61","author":"Blasberg","year":"1977","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.50.2.438","article-title":"111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases","volume":"50","author":"Mason","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0002-9343(82)90404-1","article-title":"Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography","volume":"73","author":"Grossman","year":"1982","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB12","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.41.11.1765","article-title":"Leptomeningeal metastases: 111indium-DTPA CSF flow studies","volume":"41","author":"Chamberlain","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB13","first-page":"576","article-title":"Leptomeningeal metastasis","volume":"86","author":"Chamberlain","year":"1997","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/modpathol.3880035","article-title":"The world health organisation classification of hematological malignancies report of the clinical advisory committee meeting, Airlie House, Virginia, November 1997","volume":"13","author":"Harris","year":"2000","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB15","first-page":"49","article-title":"Ommaya reservoirs for the treatment of leptomeningeal metastases","volume":"47","author":"Sandberg","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(69)90554-6","article-title":"Death after intrathecal methotrexate","volume":"2","author":"Back","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archneur.1973.00490200044005","article-title":"Necrotizing encephalopathy following intraventricular instillation of methotrexate","volume":"28","author":"Shapiro","year":"1973","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/1097-0142(197404)33:4<923::AID-CNCR2820330406>3.0.CO;2-Z","article-title":"Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors","volume":"33","author":"Norrell","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB19","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/1097-0142(197809)42:3<1211::AID-CNCR2820420326>3.0.CO;2-X","article-title":"Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia","volume":"42","author":"Skullerud","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB20","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/1097-0142(19941201)74:11<3034::AID-CNCR2820741122>3.0.CO;2-O","article-title":"Excessive spinal cord toxicity from intensive central nervous system-directed therapies","volume":"74","author":"Watterson","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB21","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/1097-0142(19940615)73:12<3037::AID-CNCR2820731223>3.0.CO;2-6","article-title":"Myelopathy after intrathecal chemotherapy. A case report with unique magnetic resonance imaging changes","volume":"73","author":"McLean","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB22","first-page":"1054","article-title":"Paraplegia and quadriplegia after intrathecal chemotherapy","volume":"69","author":"Werner","year":"1988","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0887-8994(99)00040-5","article-title":"Anterior lumbosacral radiculopathy after intrathecal methotrexate treatment","volume":"21","author":"Koh","year":"1999","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archinte.1982.00340160163029","article-title":"CSF infections complicating the management of neoplastic meningitis. Clinical features and results of therapy","volume":"142","author":"Trump","year":"1982","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3171\/jns.1990.73.5.0774","article-title":"Hemiparkinsonism as a complication of an Ommaya reservoir. Case report","volume":"73","author":"Cheshire","year":"1990","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB26","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/1097-0142(19910415)67:8<2062::AID-CNCR2820670809>3.0.CO;2-U","article-title":"Acute tumor lysis syndrome after intrathecal methotrexate administration","volume":"67","author":"Simmons","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/mpo.2950180213","article-title":"Sudden neurologic death after intrathecal methotrexate","volume":"18","author":"Shore","year":"1990","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM197310112891503","article-title":"Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia","volume":"289","author":"Bleyer","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1212\/WNL.52.1.214-b","article-title":"111Indium-diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases","volume":"52","author":"Chamberlain","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0046-8177(78)80047-1","article-title":"Methotrexate encephalopathy. A neuropathologic study","volume":"9","author":"Liu","year":"1978","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002800000118","article-title":"Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis","volume":"46","author":"Tetef","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"Suppl 3","key":"10.1016\/j.clineuro.2003.09.005_BIB32","doi-asserted-by":"crossref","first-page":"B111","DOI":"10.1007\/PL00022771","article-title":"Therapy of PCNSL at the Massachusetts General Hospital with high dose methotrexate and deferred radiotherapy","volume":"80","author":"Hochberg","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB33","first-page":"40","article-title":"High-dose methotrexate for primary CNS lymphoma in the elderly","volume":"2","author":"Ng","year":"2000","journal-title":"Neurooncology"},{"key":"10.1016\/j.clineuro.2003.09.005_BIB34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1006210703827","article-title":"Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients","volume":"43","author":"Guha-Thakurta","year":"1999","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2003.09.005_BIB35","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.1998.16.9.3000","article-title":"Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma","volume":"16","author":"Sandor","year":"1998","journal-title":"J. Clin. Oncol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846703000933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846703000933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T16:14:44Z","timestamp":1682612084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846703000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0303846703000933"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2003.09.005","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}